Nishikawa, Hiroki <br/><br/>
Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience.  [electronic resource] 

 -  Oncology reports  Sep 2012 
 - 835-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2012.1883  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Disease-Free Survival<br/>Female<br/>Hepacivirus<br/>Hepatitis C--complications<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--complications<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Rituximab<br/>Severity of Illness Index<br/>Treatment Outcome